Due to genital bleeding from the primary tumor, blood data revealed severe anemia and increased erythropoietic activity (Hb = 6.7 g/dL, RDW = 21.2%, WBC = 8.8 × 103/μL, and CRP = 0.08 mg/dL). This evidence concerns the gene GSTM1 and anemia.